Catalyst

Slingshot members are tracking this event:

FDA did not meet the PDUFA goal date for ARYMO ER (Morphine Sulfate) Extended-Release Tablets set for October 14, 2016. No news on the date the review will take place.

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
EGLT Community voting in process
Slingshot Insights Explained
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Nda, Arymo Er, Morphine Sulfate, Pain, Opioid Treatment